UNICA IRIS Institutional Research Information System

MASSA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 145.349
NA - Nord America 12.039
AS - Asia 5.543
SA - Sud America 807
AF - Africa 144
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 163.906
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 140.286
US - Stati Uniti d'America 11.854
SG - Singapore 2.072
CN - Cina 2.052
NL - Olanda 1.901
UA - Ucraina 966
SE - Svezia 648
BR - Brasile 609
VN - Vietnam 500
FI - Finlandia 394
DE - Germania 329
GB - Regno Unito 319
FR - Francia 260
HK - Hong Kong 182
KR - Corea 145
IN - India 117
CA - Canada 100
AR - Argentina 71
BD - Bangladesh 68
MX - Messico 54
ZA - Sudafrica 52
TR - Turchia 51
IQ - Iraq 49
AT - Austria 41
JP - Giappone 36
RU - Federazione Russa 35
PK - Pakistan 34
PH - Filippine 33
IR - Iran 30
EC - Ecuador 26
ES - Italia 26
ID - Indonesia 26
CO - Colombia 25
PL - Polonia 25
BE - Belgio 23
SA - Arabia Saudita 23
CL - Cile 21
IE - Irlanda 19
KE - Kenya 18
UZ - Uzbekistan 18
VE - Venezuela 18
MA - Marocco 17
CZ - Repubblica Ceca 15
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
TN - Tunisia 13
AU - Australia 12
EG - Egitto 10
MY - Malesia 10
PE - Perù 10
NP - Nepal 9
TW - Taiwan 9
BO - Bolivia 8
JM - Giamaica 8
JO - Giordania 8
RO - Romania 8
EU - Europa 7
KZ - Kazakistan 7
CR - Costa Rica 6
LT - Lituania 6
OM - Oman 6
AZ - Azerbaigian 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
LV - Lettonia 5
AM - Armenia 4
CH - Svizzera 4
GR - Grecia 4
IL - Israele 4
LB - Libano 4
NG - Nigeria 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
CG - Congo 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
MK - Macedonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
UG - Uganda 3
AO - Angola 2
BB - Barbados 2
CI - Costa d'Avorio 2
EE - Estonia 2
GA - Gabon 2
HU - Ungheria 2
LK - Sri Lanka 2
ML - Mali 2
NI - Nicaragua 2
QA - Qatar 2
Totale 163.878
Salva come PNG Salva come JPEG
Città #
Cagliari 135.259
Uta 4.291
Amsterdam 1.880
Fairfield 1.170
Singapore 1.035
Ashburn 1.022
Woodbridge 1.022
Houston 829
Chandler 678
Dallas 636
San Jose 591
Boardman 562
Jacksonville 555
Seattle 499
Wilmington 483
Ann Arbor 480
Nyköping 466
Cambridge 413
Beijing 346
Dearborn 257
Helsinki 226
Los Angeles 195
Ho Chi Minh City 189
Nanjing 174
Hong Kong 161
Hefei 158
Santa Clara 155
Boston 147
Lauterbourg 145
The Dalles 138
New York 136
Seoul 132
Shanghai 118
Buffalo 101
Guangzhou 96
Hanoi 92
San Diego 91
Milan 78
Council Bluffs 63
Munich 58
Nanchang 57
Shenyang 49
São Paulo 47
Hangzhou 45
Toronto 45
London 44
Changsha 43
Rome 43
Hebei 42
Redondo Beach 40
Tianjin 40
Chicago 36
Redwood City 36
Jiaxing 34
Frankfurt am Main 33
Jinan 32
Verona 32
Orem 30
Nuremberg 29
Tokyo 29
Norwalk 28
Rio de Janeiro 28
Orange 26
Da Nang 24
Pune 22
Warsaw 22
Brussels 21
Sassari 21
Baghdad 20
Johannesburg 20
Auburn Hills 19
Chennai 19
Vienna 19
Zhengzhou 19
Atlanta 18
Belo Horizonte 18
Brooklyn 18
Dublin 18
Haiphong 18
Kunming 18
Mountain View 18
Phoenix 18
Turku 18
Manchester 16
Mexico City 16
Tashkent 16
Wuhan 16
Dhaka 15
Montreal 15
San Francisco 14
Shenzhen 14
Stockholm 14
Ankara 13
Biên Hòa 13
Denver 13
Istanbul 13
Naples 13
San Mateo 13
Dong Ket 12
Nairobi 12
Totale 156.621
Salva come PNG Salva come JPEG
Nome #
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.878
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.980
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.947
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.823
Molecular-biology-driven treatment for metastatic colorectal cancer 2.771
Sense of coherence and physical health-related quality of life in Italian chronic patients: The mediating role of the mental component 2.712
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.636
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 2.603
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.576
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.450
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.327
VITAMIN C SUPPLEMENTATION IN CANCER CACHEXIA AND RELATED-OXIDATIVE STRESS 2.253
Health related quality of life in patients with onco-hematological diseases 2.234
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.188
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.872
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial 1.839
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.788
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial 1.773
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 1.744
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.727
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.713
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.702
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.686
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.669
The Quality of Life of People with Solid Cancer is Less Worse than Other Diseases with better Prognosis, Except in the Presence of Depression 1.666
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 1.650
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.628
Immunotherapy and Cancer: The Multi-Omics Perspective 1.609
Weight loss in cancer patients: a plea for a better awareness of the issue 1.586
Case-control Phase ii clinical trial to assess efficacy and safety, of the same antineoplastic treatment(s) in elderly "fit" compared to adult patients with cancer at different sites 1.553
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.506
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause 1.503
null 1.489
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.483
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia = Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: Final analysis of GIDEON study in Italy 1.474
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.311
null 1.306
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.283
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens 1.210
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.194
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.174
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.145
Moderate exercise improves cognitive function in healthy elderly people: results of a randomized controlled trial 1.131
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 1.075
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.059
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature 1.028
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 1.017
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 994
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 983
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 963
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 952
null 944
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 939
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 930
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 915
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 889
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 836
ALCOL E TUMORE ALLA MAMMELLA 811
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 803
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 799
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 785
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 782
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 781
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 780
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 779
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 772
null 768
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 762
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 753
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 750
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 741
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 735
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 717
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy 713
null 709
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 699
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 695
null 694
null 688
null 681
Risk factors for sentinel lymph node involvement in patients with apparent early-stage endometrial cancer: a retrospective single-center study 679
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review 670
Low adherence to therapy and co-morbid depressive episodes are independent determinants of early death in people with cancer 632
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 629
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 627
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 625
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 622
Managing cancer-related anorexia/cachexia 613
p16 Block Type Overexpression, p53 Wild Type Reactivity, and Cervical Involvement do not Always Exclude the Diagnosis of Primary Endometrial Squamous Cell Carcinoma (PESCC) 611
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 609
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 607
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 598
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 595
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer 592
Adherence to treatment in patients with solid and hematological cancers. Could spiritual and psychological support facilitate optimal adherence? 591
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 584
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 576
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 574
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 572
null 572
Totale 125.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 232.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 232.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.226 0 0 0 0 0 0 0 0 0 1.576 1.532 1.118
2021/20226.673 644 561 269 475 659 504 320 348 583 492 814 1.004
2022/202312.087 956 1.396 1.196 1.047 1.060 1.211 577 1.429 832 772 1.019 592
2023/202415.869 1.357 542 511 1.008 1.574 3.191 1.579 1.023 781 1.356 1.512 1.435
2024/202533.508 7.200 9.237 4.138 3.944 2.037 3.756 1.424 182 446 310 384 450
2025/202611.381 592 558 1.260 878 773 699 1.857 650 2.687 1.427 0 0
Totale 164.270